Antisense oligodeoxynucleotides to the kappa1 receptor enhance Δ9-THC-induced antinociceptive tolerance

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 399-404

  Rowen, David W ^a   Embrey, James P ^a   Moore, Charles H ^a   Welch, Sandra P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinociception; Antisense; Dynorphin; Kappa; Receptors; Spinal; Tolerance; 9 THC

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CANNABINOID; CANNABINOID RECEPTOR; DRONABINOL; DYNORPHIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; ANALGESIC AGENT; ANTISENSE OLIGONUCLEOTIDE; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; HYPOTHESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; ANIMAL; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; REACTION TIME; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED ICR; OLIGONUCLEOTIDES, ANTISENSE; REACTION TIME; RECEPTORS, OPIOID, KAPPA; TETRAHYDROCANNABINOL;

EID: 0031987342     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00485-1     Document Type: Article

References (45)

1. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacol. Biochem. Behav. 46:1993;575-579.
2. Aksu F., Holmes B. B., Fujimoto J. M. Opioid antagonists. Indirect antagonism of morphine analgesia by spinal dynorphin A Pharmacol. Biochem. Behav. 45:1993;409-418.
3. i-1 subunit of GTP-binding proteins. J. Neurochem. 53:1989;1636-1639.
4. 6-leucine enkephalin and DPDPE to brain membranes of morphine tolerant-dependent rats. Eur. J. Pharmacol. 202:1991;403-408.
5. Bhargava H. N., Gulati A., Ramarao P. Effect of chronic administration of U50,488H on tolerance to its pharmacological actions and on multiple opioid receptor in rat brain regions and spinal cord. J. Pharmacol. Exp. Ther. 251:1989;21-26.
6. Chen Y., Mestek A., Liu J., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
7. Chien C., Brown G., Pan Y., Pasternak G. W. Blockade of U50, 488H analgesia by antisense oligodeoxynucleotides to a k-opioid receptor. Eur. J. Pharmacol. 253:1994;R7-R8.
8. D'Amour F. E., Smith D. L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
9. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
10. Dewey W. L. Cannabinoid pharmacology. Pharmacol. Rev. 38:1986;151-178.
11. 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212. Pharmacol. Exp. Ther. 271:1994;1383-1390.
12. Harris L. S., Pierson A K. Some narcotic antagonists in the benzomorphan series. Pharmacol. Exp. Ther. 143:1964;141-148.
13. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., DeCosta B. R., Rice K. C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA. 87:1990;1932-1936.
14. Hylden J. L. K., Wilcox G. L. Intrathecal morphine in mice. A new technique Eur. J. Pharmacol. 67:1980;313-316.
15. Kest B., Orlowski M., Bodnar R. J. Endopeptidase 24.15 inhibition and opioid antinociception. Psychopharmocology (Berlin). 106:1992;408-416.
16. Lichtman A. H., Martin B. R. Spinal and supraspinal mechanisms of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258:1991;517-523.
17. Litchfield J. T., Wilcoxon F. A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
18. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., Bonner T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
19. Meng F., Xie G., Thompson R. C., Mansour A., Goldstein A., Watson S. J., Akil H. Cloning and pharmacological characterization of a rat k opioid receptor. Proc. Natl. Acad. Sci. USA. 90:1993;9054.
20. Munro S., Thomas K. L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
21. Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain. A quantitative autoradiographic study Brain Res. 616:1993;293-302.
22. 9-THC in the spinal cord. Brain Res. 689:1995;157-158.
23. 9-THC and morphine in the spinal cord. J. Pharmacol. Exp. Ther. 279:1996;608-616.
24. Raffa R. B., Martinez R. P., Connelly C. D. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception. Eur. J. Pharmacol. 258:1994;R5-R7.
25. Raynor K., Hong H., Hines J., Kong G., Benovic J., Yasuda K., Bell G. I., Reisine T. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J. Pharmacol. Exp. Ther. 270:1994;1381-1386.
26. 9-tetrahydrocannabinol treatment. Pharmacol. Biochem. Behav. 47:1994;33-40.
27. Rossi G., Pan Y., Cheng J., Pasternak G. W. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor. Life Sci. 54:1994;375-379.
28. 9-tetrahydrocannabinol-induced analgesia. Brain Res. 578:1992;8-12.
29. 9-tetrahydrocannabinol and kappa opioids in mice. J. Pharmacol. Exp. Ther. 268:1994;1381-1387.
30. Standifer K. M., Chien C., Walhlestedt C., Brown G. P., Pasternak G. W. Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotide to a delta receptor. Neuron. 12:1994;805-810.
31. Tallarida R. J., Murray R. B. Parallel lines 1. Test for parallelism Tallarida R. J., Murray R. B. Manual of pharmacologic calculations with computer programs. 1986;19-22 Springer Verlag, New York.
32. Tao P. L., Seybold V. S., Loh H. H. Autoradiographic evidence for decrease in binding of mu- and delta-opioid receptors after subchronic DADLE treatment in rats. Eur. J. Pharmacol. 231:1993;145-149.
33. Tao P. L., Tsai C. L., Chang L. R., Loh H. H. Chronic effect of DPDPE on rat brain opioid receptors. Eur. J. Pharmacol. 201:1991;209-214.
34. 9-tetrahydrocannabinol in mice. Eur. J. Pharmacol. 260:1994;5-13.
35. Thorat S. N., Reddy P. L., Bhargava H. N. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice. Brain Res. 615:1993;191-198.
36. Weintraub H. H. Antisense RNA and DNA. Sci. Am. 262:1990;40-46.
37. Welch S. P. Modulation of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-Diallyl-Tyrosine-Aib-Phenylalanine-Leucine, ICI 174,864 or naloxone in mice. J. Pharmacol. Exp. Ther. 265:1993;633-640.
38. Welch S. P. Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrozone (NalBZH). Pharmacol. Biochem. Behav. 49:1994;929-934.
39. Welch S. P., Stevens D. L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J. Pharmacol. Exp. Ther. 262:1992;10-18.
40. Welch S. P., Thomas C., Patrick G. S. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice. Possible mechanisms for interaction with morphine J. Pharmacol. Exp. Ther. 272:1995;310-321.
41. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors. Brain Res. 544:1991;145-149.
42. Yaksh T. L., Al-Rodhan N. R., Jensen T. S. Sites of action of opiates in production of analgesia. Prog. Brain Res. 77:1988;371-394.
43. Yasuda K., Raynor K., Haeyoung K., Breder C. D., Takeda J., Reisine T., Bell G. I. Cloning and functional comparison of k and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA. 90:1993;6736-6740.
44. Xia Q., Sheng J. Z., Tai K. K., Wong T. M. Effects of chronic U50,488H treatment on binding and mechanical responses of rat hearts. J. Pharmacol. Exp. Ther. 268:1994;930-934.
45. Xie G. X., Meng F., Mansour A., Thompson R. C., Hoversten M. T., Goldstein A., Watson S. J., Akil H. Primary structure and functional expression of a guinea pig k opioid (dynorphin) receptor. Proc. Natl. Acad. Sci. USA. 91:1994;3779-3783.